A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro.
Ikuo Inoue(Howard Hughes Medical Institute), J.-M. Lalouel(Howard Hughes Medical Institute), Xavier Jeunemaı̂tre(Délégation Paris 5), Toshiaki Nakajima(Dokkyo Medical University), Robert Puryear(Howard Hughes Medical Institute), Christopher S. Williams(Vanderbilt University), Akira Hata(Chiba University), John Quackenbush(Harvard University), E H Ludwig(Howard Hughes Medical Institute), Arya M. Sharma(Rutgers, The State University of New Jersey), Tong Cheng(Xiamen University), Mike Powers(Howard Hughes Medical Institute)
Cited by 550
Related Papers
Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: a case-control study
|The Lancet|2005|2.9k
The 2017 international classification of the Ehlers–Danlos syndromes
|American Journal of Medical Genetics Part C Seminars in Medical Genetics|2017|1.9k
Obesity in adults: a clinical practice guideline
|Canadian Medical Association Journal|2020|1.4k